-
Yukihiko Kawasaki
2015 Volume 6 Issue 1 Pages
3-10
Published: 2015
Released on J-STAGE: December 15, 2020
JOURNAL
FREE ACCESS
-
Toshinao Kawai, Nobuyuki Watanabe, Midori Yokoyama, Yumiko Nakazawa, F ...
2015 Volume 6 Issue 1 Pages
11-16
Published: 2015
Released on J-STAGE: December 15, 2020
JOURNAL
FREE ACCESS
Chronic granulomatous disease(CGD)is a primary immunodeficiency characterized by an inability of phagocytes to produce reactive oxygen species, resulting in recurrent life-threatening infections. Although CGD patients frequently develop inflammatory granuloma due to prolonged production of inflammatory cytokines, the treatment with corticosteroid and immunosuppressive drugs are limited because the anti-inflammation therapy for granuloma formation would increase susceptibility to infection in CGD. Herein we described two CGD patients who suffered from granulomatous interstitial pneumonia (GIP) and received thalidomide therapy for three months. Their serum level of KL-6 was high and CT lung images showed increased reticulonodular opacities. Pathological findings for GIP patient reveal inflammation and micro-granuloma formation of interstitial lung tissue, which are similar to those of hypersensitivity pneumonia. Reticulo-nodular opacities on CT image were disappeared and the KL-6 1evels were reduced after three months of thalidomide therapy in CGD patients with GIP.Although further works are required,our findings suggest that thalidomide therapy would be therapeutic effect on pulmonary inflammatory granuloma in the CGD patients.
View full abstract
-
Yuko Tasaki, Masaki Shimizu, Natsumi Inoue, Sayaka lshikawa, Kazuyuki ...
2015 Volume 6 Issue 1 Pages
17-22
Published: 2015
Released on J-STAGE: December 15, 2020
JOURNAL
FREE ACCESS
Angiopoictins(Ang)l and 2 are important regulators of endothelial cell function. To assess the role of
Ang-l and 2 dysregulation in the pathogenesis of systemic juvenile idiopathic arthritis(s-JIA)associated
macrophage activation syndrome(MAS), and to investigate clinical significance of serum Ang 2/l ratio in s-JIA/
MAS, we measured serum Ang l/2 1evels by enzyme-linked immunosorbent assay. Twenty five patients with
s-JIA including 10 patients with MAS, 11 patients with polyarticular JIA and 15 healthy children were analyzed.
Results were compared with clinical features of s-JIA. Serum Ang-l levels during MAS phase were significantly
decreased compared to those during acute phase in s-JIA patients. Serum Ang 2/1 ratio during MAS phase were
significantly elevated compared to those during acute phase in s-JIA patients. The Ang 2/l ratio was rapidly and
extremely elevated during MAS phase, Ang 2/l ratio was also rapidly decreased after treatment. The Ang 2/l
ratio correlated positively with LDH and FDP-D dimer. Serum Ang 2/l ratio levels to reflect endothelial damage
might be a promising indicator of disease activity for s-JIA/MAS.
View full abstract
-
Masaki Shimizu, Hiroaki Umebayashi, Yuzaburo lnoue, Kazuko Kasai, Utak ...
2015 Volume 6 Issue 1 Pages
23-27
Published: 2015
Released on J-STAGE: December 15, 2020
JOURNAL
FREE ACCESS
Low dose weekly methotrexate(MTX)is one of the most effective drugs in the treatment for juvenile
idiopathic arthritis(JIA).The purpose of the present study was to investigate the current state of MTX therapy
for JIA ill Japan. A questionnaire was sent to 15 pediatricians including l2 pediatric rheumatologists in Japan. It was the most common method that starting weekly dose was 6mg/m2 and dosage was increased to 10mg/m2 by 2mg/m2 every l - 2 weeks. Folate supplement was variably performed. Abdominal discomfort and nausea were frequently observed. The assessment of efficacy was performed after three months of treatment. The criteria for withdrawal or discontinuation of MTX therapy were variable. These results revealed that there was still a
significant variation of MTX treatment among institutes in Japan. Toward the establishment of all appropriate
MTX therapy,a national wide population based study is desired.
View full abstract
-
Akihiko Shimizu, Kaori Hisa, Shigeru Nomura, Yoshiaki Shikama, Tomoyuk ...
2015 Volume 6 Issue 1 Pages
28-32
Published: 2015
Released on J-STAGE: December 15, 2020
JOURNAL
FREE ACCESS
This study aimed to establish the characteristics of bone markers among pediatric patients with rheumatic
diseases. We examined correlations between bone markers and bone mineral density(BMD, and evaluated the
effect of glucocorticoid(GC)on their bone metabolism.58 %of the patients presented elevated bone resorption
marker(TRACP-5b, and only 8 % of them presented low bone formation marker (BAP),which indicates their
bone resorption is increased and formation is not suppressed. Although patients with GC therapy have Lower
BMD, their bone markers are not significantly different from those without GC therapy. In addition to GC
treatment, inflammatory cytokines and reduced physical activity also appear to contribute to the bone fragility.
Considering pathophysiology of these patients. bisphosphonates are good candidates to prevent GC-induced
osteoporosis. In conclusion, we have shown two unique aspects of bone metabolism of our patients. One is that
the bone resorption is increased in more than half of the cases. The other is that the patients with GC therapy
have lower BMD, but their bone markers are not significantly different from those without GC therapy. We need
to collect more follow-up data to establish a basis to start bisphosphonates and to evaluate the effect of them.
View full abstract
-
Masaki Shimizu, Yuko Takemoto, Maiko Takakura, Natsumi Inoue, Yuko Tas ...
2015 Volume 6 Issue 1 Pages
33-38
Published: 2015
Released on J-STAGE: December 15, 2020
JOURNAL
FREE ACCESS
Uveitis is one of the lost important symptoms other than arthritis in juvenile idiopathic arthritis(JIA).
In some cases, uveitis is refractory to anti-inflammatory treatments and can cause loss of vision. Recently,
adalimumab (ADA), a monoclonal antibody against tumor necrosis factor α, has been gaining recognition as
an important therapeutic modality for refractory uveitis. We report two patients with refractory JlA associated
uveitis, successfully treated with ADA. Patient 1;A 2-year-old Japanese girl was referred to us with arthritis of
right ankle. The diagnosis of oligo-articular JlA was made. She had uveitis. Her uveitis was refractory and oral
corticosteroid was started since she was six years old. However, her uveitis subsequently became steroid
dependent. ADA was initiated, following which her uveitis markedly improved. Oral corticosteroid therapy
was successfully tapered. She is currently undergoing treatment with ADA, and no adverse effects have
occurred. Patient 2;A 5-year-old Japanese boy was referred to us with arthritis of left knee. The diagnosis of
oligo-articular JIA was lnade. He also had u、icitis. Methotrexate(MTX)and topical steroid was started and his
arthritis and uveitis were improved. At the six-year of age, he suffered infectious mononucleosis and MTX
treatment was stopped.His uveitis was relapsed three months later. The treatment with MTX, oral and topical
corticosteroid was stated, but his uveitis subsequently became steroid dependent. ADA was initiated,following
which his uveitis markedly improved. Oral corticosteroid therapy was successfully tapered. He is currently
undergoing treatment with ADA. and no adverse effects have occurred, ADA is considered effective for the
treatment of childhood refractory uveitis,including JIA associated uveitis. Additional indication of ADA for
refractory uveitis is desired.
View full abstract
-
Sayaka Ishikawa, Masaki Shimizu, Natsumi Inoue, Yuko Tasaki, Kazuyuki ...
2015 Volume 6 Issue 1 Pages
39-42
Published: 2015
Released on J-STAGE: December 15, 2020
JOURNAL
FREE ACCESS
A20-year-old woman with undifferentiated arthritis juvenile idiopathic arthritis(JIA)developed a red
excoriated plantar skin lesion at the age of 19 years. She was diagnosed with JIA at the age of l5 years. Her
disease was controlled with the treatment of methotrexate and etanercept(ETA). Skin biopsy of plantar skin
lesion revealed a psoriasiform hyperplasia in the epidermis. The diagnosis of psoriasiform skin lesion induced
by ETA was made. There was no improvement with topical antibiotics and steroids. Because of severe skin
lesions,ETA was discontinued and tocilizumab therapy was started. The skin lesions had resolved six months
later. Psoriasifbrm skin lesions induced by TNF-α antagonists are rare,but pediatricians should remain aware
of the possibility of psoriasis arising in JIA patients treated with TNF-α antagonists.
View full abstract
-
Harumi Akaike, Hiroyuki Imanaka, Yasuhito Nerome, Tomohiro Kubota, Tsu ...
2015 Volume 6 Issue 1 Pages
43-48
Published: 2015
Released on J-STAGE: December 15, 2020
JOURNAL
FREE ACCESS
We herein report two cases comprising three pregnancies associated with juvenile idiopathic arthritis(JIA)、
The first patient was a 31-year-old female with rheumatoid factor(RF)-positive poly-JIA and systemic
lupus erythematosus. She wished to conceive at 27 years of age after undergoing successfull treatment with
methotrexate and infliximab. She became pregnant after the discontinuation of these drugs;however,the
arthritis flared up. At gestational week(GA)34、 she delivered a baby weighing 982g via Caesarean section due
to severe intrauterine growth restriction. She subsequently conceived a second child under conditions of a
moderate disease activity despite the administration of etanercept. At GA 25, she delivered a baby weighing
592g via emergent Caesarean section due to preeclampsia, The second patient was an l6-year-old female with
RF positive poly-JIA. ADA was discontinued without any flare-ups when unexpected pregnancy was identified.
At GA 37,she gave birth to a child weighing 2,932g.
Based on our experience, we believe that patients with JIA who are considering pregnancy or who become
pregnant should achieve good control of their disease activity with an appropriate form of effective treatment,
Intensive obstetric care is also required throughout pregnancy. Furthermore, Pediatric rheumatologists should
be careful to check for not only psychological, but also sexual issues,in adolescent JIA patients.
View full abstract
-
Mao Mizuta, Kazuko Kasai, Yasuo Nakagishi, Mari Miyoshi
2015 Volume 6 Issue 1 Pages
49-52
Published: 2015
Released on J-STAGE: December 15, 2020
JOURNAL
FREE ACCESS
This case is l4 years old girl who diagnosed with polyarticular juvenile idiopathic arthritis at the age of
10 years old. Rheumatoid factor and anti-cyclic citrullinated peptide antibody is positive. She has a congenital
heart disease which is a common atrium, atrioventricular septal defect, absence of the inferior vena cava, and
polysplenia syndrome. She was operated for two ventricular repair and mitral valve plasty at the age of l year
old. At first、 we started to use the medicine of PSL and MTX, however the effect is limited for her. So we
planned use of biologics (Tocilizumab). It is unknown the side effect against heart damage of using
Tocilizumab. We assessed that her cardiac function was normal. Therefore we treated her with Tocilizumab.
Her cardiac function remains stable. It is suggested that the use of Tocilizuinab is safe for JIA with congenital
heart disease.
View full abstract
-
Tomomi Sato, Satoko Obayashi, Yusuke Okuda, Tomoyuki Sakai, Toshihiro ...
2015 Volume 6 Issue 1 Pages
53-56
Published: 2015
Released on J-STAGE: December 15, 2020
JOURNAL
FREE ACCESS
The patient ill this case was a 17-year-old girl with systemic lupus erythematosus (SLE). Ten years after
onset, the SLE recurred accompanied by nephrotic syndrome. Lupus nephritis of International Society of
Nephrology class lV G(A/C)was diagnosed according to kidney biopsy results. The patient underwent 4
courses of steroid pulse therapy. but her urinary protein levels gradually increased. Her systemic symptoms
included marked edema and accumulation of pleuroperitoneal and pericardial fluids. She was admitted to the
hospital at age 17 years 6 months. Plasmapheresis was performed to eliminate autoantibodies,which improved
the nephrotic symptoms and relieved the edema and accumulated pleuroperitoneal and pericardial fluids.
Thereafter,the urinary protein levels gradually decreased. Cyclophosphamide pulse therapy was selected as
maintenance immunosuppression therapy. After 8 months, remission of the nephrotic syndrome was achieved、
Lupus nephritis is a serious complication of SLE, which can be a determining factor of patient quality
of life and prognosis. In addition to steroids, combined use of mycophenolate mofetil and cyclophosphamide
pulse therapy is necessary for the treatment of lupus nephritis class IV. In severe cases of nephrotic syndrome,
plasmapheresis is considered as all effective, life-saving treatment in the acute phase.
View full abstract
-
Noriko Fujii, Ayaka Kitamura, Kazutaka Ouchi, Toru Morihara, Shinji Ak ...
2015 Volume 6 Issue 1 Pages
57-61
Published: 2015
Released on J-STAGE: December 15, 2020
JOURNAL
FREE ACCESS
Arthritis is one of the major complications in mixed connective tissue disease (MCTD). It is mostly
presented with non-erosive, mild-to-moderate synovitis. We describe a MCTD case of 14-years-old girl、who
had a shoulder pain during MTX therapy for refractory constitutional symptoms at three years after onset.
Arthroscopy revealed pannus formation with massive bone erosive area, which was a close resemble to
synovitis in rheumatoid arthritis. She was diagnosed as MTX-resistant arthritis with MCTD and was
successfully treated with synovectomy followed by tocilizumab, an effective biologics for rheumatoid arthritis.
This case reminds us the importance of practical interventions based on pathophysiologic features, especially
when facing multisystem disorders such as collagen diseases. Also suggests tocilizumab has a therapeutic
potential for treating arthritis with collagen diseases.
View full abstract
-
Junya Shimizu, Yumi Ojima, Hiroki Tsuchiya, Mariko Hattori, Yuki Hyodo ...
2015 Volume 6 Issue 1 Pages
63-67
Published: 2015
Released on J-STAGE: December 15, 2020
JOURNAL
FREE ACCESS
It is extremely rare that Behcet's disease arises as a complication of nephrotic syndrome(NS). The case
described herein is that of a l3-year-old boy. NS onset occurred at six years old, progressing to frequently
relapsing NS. However, mizoribin(MZR)high-dose therapy can achieve long-term remission. He came to
repeat erythema and stomatitis from MZR high-dose therapy. Orthodontic therapy had been started. He was
diagnosed as having Behcet's disease taking the ocular attack as an opportunity 7 years after NS development.
Human lymphocyte antigen(HLA)typing was positive for HLA-B51.
The causes of Behcet’s disease and NS remain unclear. ln this case, therapeutic agents including
steroids and MZR, as well as HLA and oral mucosal irritation, might have affected Behcet's disease development.
This extremely interesting case is useful to elucidate the pathogenic mechanism of Behcet's disease.
View full abstract
-
Kazuko Kasai, Mao Mizuta, Yasuo Nakagishi, Hirokazu Sakamoto, Mari Miy ...
2015 Volume 6 Issue 1 Pages
69-72
Published: 2015
Released on J-STAGE: December 15, 2020
JOURNAL
FREE ACCESS
Parry-Romberg syndrome is a rare neurocutaneous syndrome characterized by slow progressive
hemifacial atrophic changes. This report presents a rare case of Parry-Romberg syndrome associated with
localized sclerodernia. A 7-year-old female presented with white linear atrophy of the right lower lip and a
white spot on the right submaxilla. As the atrophy spread diffusely to the right cheek and submaxilla, the right
half of the patient's face became deformed for 5 mollths. In parallel, the white spot lesion multiplied on the
right supermaxilla, the right buccal mucosa. and the right side of the tongue. Examination of tissue from the
white spot revealed infiltration of inflammatory cells and deposition of collagenous fibers in the dermis,
indicating localized scleroderma. Though PRS is a rare syndrome, we should think about association with
localized scleroderlna.
View full abstract
-
Sayaka Ishikawa, Masaki Shimizu, Natsumi Inoue, Yuko Tasaki, Kazuyuki ...
2015 Volume 6 Issue 1 Pages
73-76
Published: 2015
Released on J-STAGE: December 15, 2020
JOURNAL
FREE ACCESS
A 10-year-old girl had a right hip pain from 2 years earlier, and was referred to us with a 3-month
history of pain and functional impairment in the right hip. Physical examinations were unremarkable, except
of muscle wasting of her right thigh. She had severely restricted range of motion of right hips, with a flexion
contracture of the right hip. Standard radiograph of the pelvis showed loss of joint space in the right hip. MRI
of the hip revealed narrowing of the right hip joint space and bone marrow edema within right femoral head
with cartilage loss and small volume of joint effusion with no signs of synovial thickening or enhancement
which is characteristic of juvenile idiopathic arthritis(JIA). The diagnosis of idiopathic chondrolysis of hip
(ICH)was made. The treatment of intra-articular corticosteroid injection followed by oral ibuprofen and
physiotherapy was started. Her symptoms and standard radiograph findings improved 6 months later.
ICH is an unknown cause pediatric musculoskeletal disorder. It presents with progressive articular
cartilage destruction and joint space narrowing, resulting in secondary osteoarthritis. The cardinal symptoms
of lCH are strong pain of hip joint and disturbance of excursion. ICH occurs predominantly in adolescent girls,
therefere, it is necessary to be differentiated from JIA.
View full abstract